ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1,2,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4,2,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
5,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
5,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5,3,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
5,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
6,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
7,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
8,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
9,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
10,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
12,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
13,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
13,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
13,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
13,4,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
13,5,Spinal cord disorder,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
14,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
14,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
14,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
15,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
15,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
15,3,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
15,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
15,5,Nail bed infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
15,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
15,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
15,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
16,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
17,1,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
18,1,Invasive lobular breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
18,2,Lobular breast carcinoma in situ,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
18,3,Phyllodes tumour,Breast neoplasms unspecified malignancy,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
19,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
20,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
21,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
21,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
21,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
21,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
22,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
22,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
24,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
24,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
24,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
24,4,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
25,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
25,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
25,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
25,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
26,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
27,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
27,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
27,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
27,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
28,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
28,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
29,1,Cardiac amyloidosis,Cardiomyopathies,Myocardial disorders,Card,Y
29,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
29,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
30,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
31,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
32,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
32,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
33,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
33,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
34,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
34,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
36,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
36,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
36,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
37,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
38,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,2,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
39,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
40,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
40,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
40,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
41,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
42,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
42,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
42,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
42,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
43,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
44,1,Actinomycosis,Actinomycotic infectious disorders,Bacterial infectious disorders,Infec,N
44,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
44,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
44,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
46,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
47,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
47,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
48,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
48,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
49,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
49,2,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
49,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
50,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
50,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
50,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
50,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
51,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
51,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
52,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
52,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
53,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
54,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
55,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
57,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
57,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
58,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
58,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
58,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
59,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
60,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
60,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
60,3,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
61,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
62,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
63,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
63,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
65,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
65,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
66,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
66,2,Lumbar vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
67,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
68,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
68,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
68,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
69,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
70,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
70,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
71,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
71,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
72,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
73,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
74,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
75,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
75,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
75,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
75,4,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
75,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
75,6,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
75,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
75,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
76,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
76,2,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
76,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
76,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
76,5,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
77,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
79,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
79,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
79,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
79,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
79,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
80,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
81,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
81,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
82,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
82,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
82,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
83,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
84,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
85,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
86,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
87,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
88,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
89,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
89,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
89,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
89,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
90,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
91,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
91,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
92,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
92,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
92,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
92,4,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
92,5,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
92,6,Urticarial vasculitis,Urticarias,Angioedema and urticaria,Skin,N
93,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
93,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
93,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
93,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
93,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
93,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
93,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
93,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
93,9,Haemorrhoidal haemorrhage,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
93,10,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
93,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
93,12,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
93,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
93,14,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
93,15,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
93,16,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
93,17,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
94,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
95,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
96,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
96,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
96,3,Dissociative identity disorder,Dissociative states,Dissociative disorders,Psych,N
96,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
96,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
96,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
96,7,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
96,8,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
97,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
97,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
97,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
97,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
97,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
97,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
97,7,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
98,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
98,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
99,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
99,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
99,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
100,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
100,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
100,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
100,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
100,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
100,6,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
100,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
100,8,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
100,9,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
100,10,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
100,11,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
101,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
102,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
102,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
102,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
103,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
103,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
103,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
104,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
105,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
105,2,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
105,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
105,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
105,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
105,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
105,7,Food aversion,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
105,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
105,9,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
105,10,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
105,11,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
105,12,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
105,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
105,14,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
105,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
105,16,Paraproteinaemia,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
105,17,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
105,18,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
106,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
106,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
106,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
106,4,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
106,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
106,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
107,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
107,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
107,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
107,4,Paraproteinaemia,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
107,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
107,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
108,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
108,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
109,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
109,2,Chillblains,Conditions caused by cold,Injuries by physical agents,Inj&P,N
109,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
109,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
109,5,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
109,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
109,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
109,8,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
109,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
109,10,Vertebral lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
110,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
110,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
110,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
110,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
110,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
110,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
110,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
110,8,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
111,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
112,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
113,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
113,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
113,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
113,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
113,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
113,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
113,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
114,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
114,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
115,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
116,1,Plasma cell myeloma refractory,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
117,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
118,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
119,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
120,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
121,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
122,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
123,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
123,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
123,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
123,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
123,5,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
123,6,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
123,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
123,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
123,9,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
123,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
123,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
123,12,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
124,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
125,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
125,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
125,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
126,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
126,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
126,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
127,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
127,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
127,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
127,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
127,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
128,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
128,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
128,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
129,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
130,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
131,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
131,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
131,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
131,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
131,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
132,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
132,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
132,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
132,4,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
132,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
132,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
133,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
134,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
135,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
135,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
136,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
136,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
137,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
137,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
137,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
137,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
138,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
138,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
139,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
140,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
141,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
141,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
141,3,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
141,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
141,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
141,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
141,7,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
141,8,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
141,9,Varicophlebitis,Varicose veins NEC,Venous varices,Vasc,N
142,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
142,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
142,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
142,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
142,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
142,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
142,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
142,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
143,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
143,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
144,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
144,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
145,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
146,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
146,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
146,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
147,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
147,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
147,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
148,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
148,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
148,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
148,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
148,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
149,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
150,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
150,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
151,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
151,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
151,3,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
151,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
152,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
152,2,Immunoglobulins decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
152,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
152,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
152,5,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
153,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
153,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
153,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
153,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
153,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
153,6,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
153,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
154,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
155,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
155,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
156,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
157,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
158,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
158,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
159,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
160,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
160,2,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
160,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
160,4,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
160,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
160,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
160,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
160,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
161,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
162,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
162,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
163,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
163,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
163,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
163,4,N-terminal prohormone brain natriuretic peptide decreased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
163,5,N-terminal prohormone brain natriuretic peptide increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
163,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
163,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
163,8,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
163,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
164,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
164,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
164,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
165,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
165,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
165,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
165,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
166,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
166,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
167,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
168,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
169,1,Androgenetic alopecia,Alopecias,Skin appendage conditions,Skin,N
170,1,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
171,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
171,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
171,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
171,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
171,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
171,6,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
171,7,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
171,8,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
171,9,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
171,10,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
171,11,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
171,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
171,13,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
171,14,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
171,15,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
171,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
172,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
172,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
172,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
173,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
173,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
173,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
174,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
174,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
175,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
175,2,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
175,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
175,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
175,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
176,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
177,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
177,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
177,3,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
178,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
178,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
178,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
179,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
179,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
180,1,Cerebral nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
180,2,Pulmonary nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
181,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
182,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
183,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
183,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
184,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
185,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
185,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
185,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
185,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
185,5,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
186,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
186,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
187,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
187,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
187,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
187,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
187,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
188,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
188,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
188,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
189,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
189,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
190,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
190,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
190,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
190,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
190,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
191,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
191,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
191,3,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
191,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
191,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
191,6,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
191,7,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
191,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
191,9,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
191,10,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
191,11,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
191,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
191,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
192,1,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
192,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
193,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
193,2,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
193,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
193,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
194,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
194,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
195,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
195,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
196,1,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
196,2,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
196,3,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
196,4,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
197,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
198,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
198,2,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
198,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
199,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
199,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
199,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
199,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
200,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
201,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
201,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
202,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
202,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
203,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
203,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
204,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
204,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
204,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
205,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
205,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
205,3,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
205,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
205,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
206,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
207,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
208,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
208,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
209,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
210,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
211,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
212,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
213,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
213,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
214,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
214,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
215,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
216,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
217,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
218,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
219,1,Adjusted calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
219,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
220,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
220,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
221,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
221,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
221,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
221,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
222,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
222,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
222,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
223,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
224,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
225,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
226,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
226,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
227,1,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
228,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
228,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
229,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
229,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
